Federal healthcare programs are focusing increasingly on reducing prescription drug spending for the government programs as well as patients. […]
Read moreLatest Posts
Medicare Reviews Seniors’ Spine Operations at Surgery Centers
The Medicare program is reviewing whether seniors should undergo spine surgeries conducted same-day at surgery centers. The review will examine[…]
Read moreAppealing Can Eventually Successfully Overcome Claims Denials and GIRS Can Help
Anthem Insurance Companies, Inc., overturned a large number of denied reimbursement claims from patients that have gone to the[…]
Read moreCMS Proposes Telehealth Coding and Payment Changes for CY 2019
On July 12, 2018, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes proposals to[…]
Read morePrevention of Inappropriate Billing Leads to the Assignment of a Specific Code for a Biologic
Competitors and coding experts were recommending incorrect codes for our client’s biologic and similar products that were being billed with[…]
Read moreGIRS Payer Advocacy Compass® Quarterly Newsletter
In the last quarter, the Payer Advocacy Compass® team at Global Integrated Reimbursement Services, Inc. (GIRS) has made major strides[…]
Read moreThe GIRS PAC® Team Garners Positive Coverage and Greater Market Access for Over 4 Million Patients in New York
The GIRS Payer Advocacy® (PAC) Team began working with a significant Payer in the New York area in April 2018[…]
Read moreExpert Payer Advocacy by the GIRS PAC® Team Yields Positive Coverage for a Breakthrough Medical Device
The GIRS Payer Advocacy Compass® (PAC) team began work with a prominent payer in May 2018 to obtain positive coverage[…]
Read moreCMS proposes calendar year 2019 and 2020 payment and policy changes for Home Health Agencies and Home Infusion Therapy Suppliers
On July 2, 2018, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule [CMS-1689-P] outlining proposed Calendar[…]
Read moreThe GIRS Value Discovery Landscape Assessments® Lays the Foundation for Market Access for a Unique Product
A manufacturer with a unique product that appeared to be a drug-device partnered with the GIRS Value Discovery Landscape Assessments®[…]
Read more